ACTRN12621000674831
Recruiting
Phase 4
A multi-centre randomised controlled trial of post-operative doxycycline assessing recovery in patients undergoing endoscopic sinus surgery for the treatment of chronic rhinosinusitis
Dr. Andrew James Wood0 sites50 target enrollmentJune 3, 2021
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Chronic rhinosinusitis
- Sponsor
- Dr. Andrew James Wood
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patient undergoing Bilateral Comprehensive Endoscopic Sinus Surgery for the treatment of chronic rhinosinusitis as defined by the European Position Statement, 2020
Exclusion Criteria
- •Prior sinus surgery
- •Predisposing condition (e.g. Aspirin exacerbated respiratory disease, Granulomatosis with Polyangitis, Cystic fibrosis)
- •Antibiotic usage in the 4 weeks prior to recruitment.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
A Randomized Controlled Multicenter Trial of Post-Suicide Attempt Case Management for the Prevention of Further Attempts in Japan (ACTION-J)suicide attemptsJPRN-C000000444Health Labour Sciences Research Grant Research on Psychiatric and Neurological Diseases and Mental Health Japanese Multimodal Intervention Trials for Suicide Prevention (J-MISP)914
Active, not recruiting
Phase 3
Trial of sertraline to prevent post-traumatic brain injury depressioDepressive disorder after traumatic brain injuryMental and Behavioural DisordersISRCTN17518945King's College Hospital514
Completed
Not Applicable
Internet-based relapse prevention for in-patients with anorexia nervosaSevere anorexia nervosa (AN)Mental and Behavioural DisordersEating disordersISRCTN18274621South London and Maudsley NHS Foundation Trust (UK)98
Recruiting
Phase 3
Australasian Resuscitation In Sepsis Evaluation Randomised Controlled TrialACTRN12608000053325Australian and New Zealand Intensive Care Research Centre1,600
Not yet recruiting
Phase 3
Multicentre randomised controlled trial of minimally-invasive surfactant therapy in preterm infants 29-32 weeks gestation on continuous positive airway pressureACTRN12611000917932Menzies Institute of Medical Research, University of Tasmania454